Treatment for Influenza-Positive Patients

Antiviral Therapy

The American Thorax Society recommends oseltamivir as the primary antiviral treatment for confirmed influenza, with a standard adult dose of 75 mg orally every 12 hours for 5 days 2, 3, 1
The American College of Physicians suggests that oseltamivir should be initiated as soon as possible, ideally within 48 hours of symptom onset, when benefit is greatest 1, 2, 3
Key eligibility criteria for antiviral treatment include acute influenza-like illness with fever >38°C, and symptomatic for ≤48 hours 2, 3, 1
Hospitalized patients who are severely ill should receive oseltamivir even if >48 hours from symptom onset, particularly if immunocompromised 2, 3, 1

The American Journal of Infection recommends that previously healthy adults with influenza do NOT routinely require antibiotics, as influenza is a viral illness and antibiotics have no effect on the virus itself 6, 2, 3, 1
Consider antibiotics only if worsening symptoms develop, patient is at high risk of complications, or confirmed or suspected bacterial pneumonia on imaging or clinical grounds 6, 2, 3, 1
For non-severe influenza-related pneumonia, first-line antibiotic therapy includes Co-amoxiclav or tetracycline, while alternative options include macrolide or fluoroquinolone 6, 2, 3, 1
For severe influenza-related pneumonia, immediate IV combination therapy is required, including Co-amoxiclav or 2nd/3rd generation cephalosporin PLUS macrolide 6, 2, 3, 1

The Praxis Medical Insights guideline recommends that all patients should receive antipyretics for fever control, adequate hydration, and rest and symptom monitoring 1

The American Journal of Transplantation suggests that immunocompromised patients may require longer treatment courses and consideration of IV antivirals if severely ill, and reducing immunosuppression in patients with significant disease 4, 5, 8